SOT FDA Colloquia Series Will Include Webcast on the Toxicology of Nanoparticles

Bergeson & Campbell, P.C.
Contact

Bergeson & Campbell, P.C.

The Society of Toxicology (SOT) in conjunction with the U.S. Food and Drug Administration (FDA) Center for Food Safety and Applied Nutrition (CFSAN) have partnered to provide a colloquia series on Emerging Toxicological Science:  Challenges in Food and Ingredient Safety.  The colloquia will present scientific information that is high-quality, cutting-edge, future-oriented toxicological science and is intended to provide a well-grounded foundation to inform the work of FDA employees.  On April 8, 2021, there will be a live webcast on the toxicology of nanoparticles.  Richard Canady, Ph.D., and Kapal Dewan, MS, CLSp(CG), are Colloquium Co-Chairs.  The agenda includes:

  • Welcome, George Daston, SOT President, Procter & Gamble Company;
  • Overview and Speaker Introductions, Richard Canady, Ph.D., NeutralScience LC3;
  • Lessons Learned from Nanomaterial Characterization: Critical Quality Attributes that Influence Biological Properties, Anil Patri, Ph.D., National Center for Toxicological Research (NCTR);
  • Standard Dose Measurement for Nanomaterials: What to Include in Exposure and Toxicity so That We Can Bound Dose Estimates for Safety?, Christie Sayes, Ph.D., Baylor University;
  • Dosing-Related Challenges in Toxicity Studies and Risk Assessment of Titanium Dioxide in Food, Walter Brand, Ph.D., National Institute for Public Health and the Environment (RIVM) in The Netherlands;
  • Practical Application to Regulatory Toxicology: Issues Faced in Consideration of Developing Health Guideline Values, Lynne Haber, Ph.D., University of Cincinnati Risk Science Center; and
  • Roundtable discussion moderated by Richard Canady, Ph.D., and including all speakers, as well as Timothy Duncan, Ph.D., FDA, and Agnes Oomen, Ph.D., RIVM.

The webcast is open to the public at no charge.  Registration will require creating an online account.  SOT notes that these sessions are not a public forum to discuss toxicology regulatory issues.

[View source.]

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Bergeson & Campbell, P.C. | Attorney Advertising

Written by:

Bergeson & Campbell, P.C.
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Bergeson & Campbell, P.C. on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide